09:41 AM EST - Willow Biosciences Inc. : Announced today a follow-on engagement with Sandhill One, LLC for the next phase in optimizing a proprietary enzyme vital to the development of a large volume Active Pharmaceutical Ingredient used in nutraceutical and pharmaceutical products. This represents the continuation of the project, the first phase of which the Company announced May 31, 2022. Willow Biosciences Inc.
shares T.WLLW are trading unchanged at $0.12.
